Black race is independently associated with underutilization of transplantation for clinical T1 hepatocellular

Kavin Sugumar1, Sarah C Markt2, Jonathan J Hue1

  • 1Department of Surgery, Division of Surgical Oncology, University Hospitals Cleveland Medical Center, Cleveland, OH, USA.

Insights

Black patients with early hepatocellular carcinoma (HCC) are less likely to receive a liver transplant but more likely to undergo resection compared to White patients. These racial disparities in operative management require further investigation and intervention.

Area of Science:

  • Hepatobiliary surgery
  • Surgical oncology
  • Health disparities research

Background:

  • Hepatocellular carcinoma (HCC) is a significant cause of cancer-related mortality globally.
  • Current operative management for early-stage HCC includes ablation, surgical resection, and liver transplantation.
  • Understanding racial variations in treatment is crucial for addressing health inequities.

Purpose of the Study:

  • To compare the operative management of early-stage hepatocellular carcinoma (HCC) across different racial groups.
  • To identify potential racial disparities in the utilization of liver resection and transplantation for HCC.

Main Methods:

  • Utilized the National Cancer Database (2004-2016) to identify patients with cT1 HCC and low comorbidity (Charlson-Deyo score 0-1).
  • Compared operative versus non-operative management, and specific surgical interventions (resection vs. transplantation) by race.
  • Employed marginal standardization of logistic regression models, adjusting for clinico-demographic factors, to estimate treatment probabilities in specific patient subgroups (e.g., <70 years, insured).

Main Results:

  • A total of 25,029 patients were analyzed (20,410 White, 4,619 Black).
  • Black race was independently associated with a lower overall likelihood of operative intervention (OR 0.89, p=0.009).
  • Black patients showed a higher likelihood of resection (OR 1.23, p<0.001) and a lower likelihood of transplantation (OR 0.60, p<0.001).
  • Marginal standardization confirmed Black race was linked to increased resection probability (especially in patients >50 years with private insurance/Medicare) and decreased transplantation probability across age and insurance groups.

Conclusions:

  • Racial disparities exist in the surgical management of early hepatocellular carcinoma (HCC).
  • Black patients are disproportionately favored for liver resection and disfavored for liver transplantation compared to White patients.
  • The multifactorial etiology of these disparities necessitates targeted interventions to ensure equitable care for all HCC patients.
Abstract

Related Concept Videos

Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
570
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
74
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
556